The orally bioavailable met inhibitor PF-2341066 inhibits osteosarcoma growth and osteolysis/matrix production in a xenograft model (Q39594896)
Jump to navigation
Jump to search
scientific article published on June 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The orally bioavailable met inhibitor PF-2341066 inhibits osteosarcoma growth and osteolysis/matrix production in a xenograft model |
scientific article published on June 2011 |
Statements
1 reference
The orally bioavailable met inhibitor PF-2341066 inhibits osteosarcoma growth and osteolysis/matrix production in a xenograft model (English)
1 reference
Erik R Sampson
1 reference
Brad A Martin
1 reference
Aimee E Morris
1 reference
Chao Xie
1 reference
Edward M Schwarz
1 reference
Regis J O'Keefe
1 reference
Randy N Rosier
1 reference
1 June 2011
1 reference
1 reference
1283-1294
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference